±¹È¸ ¹ý¾È Åë°ú¿¡ ¼ù°¡¶ô ¾ñ´Â º¹ÁöºÎÀÇ '»ý»ö ¼±¾ð'
º¸°Çº¹ÁöºÎ ¼Ò°ü 'ÈÀåǰ»ê¾÷À°¼º¹ý' Á¦Á¤ ¹× '°£È£¹ý'¡¤'¾à»ç¹ý' °³Á¤¾È ±¹È¸ Àǰá
ÈÀåǰ Á¾ÇÕ°èȹ ¼ö¸³, °£È£»ç 1Àδç ȯÀÚ ¼ö ±âÁØ ¸¶·Ã, DUR ¸¶¾à·ù È®ÀÎ Àǹ«È
ÈÀåǰ Á¾ÇÕ°èȹ ¼ö¸³, °£È£»ç 1Àδç ȯÀÚ ¼ö ±âÁØ ¸¶·Ã, DUR ¸¶¾à·ù È®ÀÎ Àǹ«È
°¡¿äÁø ±âÀÚÀÔ·Â : 2026. 08. 24(¿ù) 13:59

»çÁø=º¸°Çº¹ÁöºÎ Á¦°ø
[º¸°Çº¹ÁöºÎ/CTN]°¡¿äÁø ±âÀÚ= Á¤Àº°æ º¸°Çº¹ÁöºÎ Àå°üÀÌ À̲ô´Â º¸°Çº¹ÁöºÎ´Â ±¹È¸ º»È¸ÀÇ¿¡¼ ÈÀåǰ»ê¾÷ À°¼º ¹× Áö¿ø¿¡ °üÇÑ ¹ý·ü Á¦Á¤¾È°ú ±¹¹Î¿¬±Ý¹ý, ¾à»ç¹ý, °£È£¹ý ÀϺΰ³Á¤¾È µî ¼Ò°ü 10°³ ¹ý·ü¾ÈÀÌ ÀǰáµÇ¾ú´Ù°í ¹àÇû´Ù. º¹ÁöºÎ´Â ±¹È¸ º»È¸ÀǸ¦ Åë°úÇÑ ¼Ò°ü ¹ý¾ÈµéÀÇ ÁÖ¿ä ³»¿ë°ú ÇâÈÄ ¹ý ½ÃÇà °èȹÀ» ¹èÆ÷Çß´Ù.
º¹ÁöºÎ¿¡ µû¸£¸é Á¦Á¤µÈ ÈÀåǰ»ê¾÷À°¼º¹ýÀº Á¾ÇÕ°èȹ ¼ö¸³°ú Çõ½ÅÇü ±â¾÷ ÀÎÁõ, ÇØ¿Ü ÁøÃâ Áö¿øÀ» ±ÔÁ¤Çϰí ÀÖÀ¸¸ç, °£È£¹ý °³Á¤¾ÈÀº °£È£»ç 1¸í´ç ÀûÁ¤ ȯÀÚ ¼ö ±âÁØ ¸¶·Ã°ú ¹èÄ¡ ÇöȲ °ø°³¸¦ ¸í½ÃÇß´Ù.
¶ÇÇÑ ¾à»ç¹ý °³Á¤¾ÈÀº ¸¶¾à·ù Á¶Á¦ ½Ã DUR È®ÀÎÀ» Àǹ«ÈÇÏ°í ºñ´ë¸é Áø·á Áß°³¾÷ÀÚ °ü·Ã µµ¸Å»ó °á°Ý»çÀ¯¸¦ ½Å¼³ÇßÀ¸¸ç, ±¹¹Î¿¬±Ý¹ý °³Á¤¾ÈÀº ´ëüÅõÀÚ ½Ã ESG ¿ä¼Ò °í·Á ±âÁØÀ» ¸¶·ÃÇß´Ù.
ÀÔ¹ýºÎ¿¡¼ Åë°úµÈ °üÇÒ º¸°Ç¡¤º¹Áö¡¤ÀÇ·á ¹ý¾ÈµéÀÇ Á¦¡¤°³Á¤ »ç½ÇÀ» ¾Ë¸®°í ÇâÈÄ ½ÃÇà ÀÏÁ¤À» ¾È³»ÇÏ´Â °ÍÀº Á¤ºÎ ºÎóÀÇ ´ç¿¬ÇÑ ÇàÁ¤ ÀýÂ÷´Ù.
´Ù¸¸ ±¹È¸ ÀÔ¹ý ¼º°ú¿¡ ¼ù°¡¶ôÀ» ¾ñÀ¸¸ç ¸¶Ä¡ ÀÚºÎÇÒ ¸¸ÇÑ °ÅâÇÑ Á¦µµÀû Çõ½ÅÀÌ ´çÀå ¿Ï¼ºµÈ °Íó·³ Æ÷ÀåÇÏ´Â °ÍÀº º¸¿©ÁÖ±â½Ä ÇàÁ¤À̶ó´Â ÁöÀûÀ» ÇÇÇÏ±â ¾î·Æ´Ù. ¹ý¾È Åë°ú »ç½ÇÀ» È«º¸ÇÏ´Â ¼±¾ðÀû ¹ßÇ¥¿¡ ¸Ó¹° °ÍÀÌ ¾Æ´Ï¶ó, °£È£»ç ÀûÁ¤ ¹èÄ¡ ±âÁØÀÇ ½ÇÈ¿¼º ÀÖ´Â ¼ö°¡ ¿¬°è³ª ¸¶¾à·ù °ü¸® ½Ã½ºÅÛ ¿î¿µ µî ÇöÀå¿¡¼ ÀÛµ¿ÇÒ ¼ö ÀÖ´Â ±¸Ã¼ÀûÀÎ ÇÏÀ§ ¹ý·É°ú ¿¹»ê¾ÈÀ¸·Î ÁøÁ¤¼ºÀ» Áõ¸íÇØ¾ß ÇÑ´Ù.
[¿µ¹®¹ø¿ª ±â»ç-AIȰ¿ë]
Eun-kyeong Jeong, Minister of Health and Welfare, oversees the implementation as the Ministry of Health and Welfare announced that 10 bills under its jurisdiction, including the Cosmetic Industry Promotion Act and amendments to the Nursing Act, passed the National Assembly. The ministry released details regarding the newly passed legislation and upcoming enforcement schedules.
According to the ministry, the Cosmetic Industry Promotion Act establishes comprehensive support frameworks for K-beauty companies, while the revised Nursing Act mandates guidelines for appropriate nurse-to-patient ratios.
Additionally, the revised Pharmaceutical Affairs Act enforces Mandatory DUR verification for narcotic prescriptions, and the National Pension Act revision incorporates ESG standards into alternative investment guidelines.
While publicizing the legislative passage of sector-specific welfare bills and providing guidance on upcoming administrative timelines presents a plausible narrative for public health governance, skepticism remains.
Critics point out that broadcasting legislative approvals to claim executive achievements borders on administrative showmanship and excessive self-praise. Rather than relying on ceremonial publicity over passed bills, the health ministry needs practical results, such as formulating detailed enforcement decrees, securing implementation budgets, and establishing measurable monitoring systems on site.
º¹ÁöºÎ¿¡ µû¸£¸é Á¦Á¤µÈ ÈÀåǰ»ê¾÷À°¼º¹ýÀº Á¾ÇÕ°èȹ ¼ö¸³°ú Çõ½ÅÇü ±â¾÷ ÀÎÁõ, ÇØ¿Ü ÁøÃâ Áö¿øÀ» ±ÔÁ¤Çϰí ÀÖÀ¸¸ç, °£È£¹ý °³Á¤¾ÈÀº °£È£»ç 1¸í´ç ÀûÁ¤ ȯÀÚ ¼ö ±âÁØ ¸¶·Ã°ú ¹èÄ¡ ÇöȲ °ø°³¸¦ ¸í½ÃÇß´Ù.
¶ÇÇÑ ¾à»ç¹ý °³Á¤¾ÈÀº ¸¶¾à·ù Á¶Á¦ ½Ã DUR È®ÀÎÀ» Àǹ«ÈÇÏ°í ºñ´ë¸é Áø·á Áß°³¾÷ÀÚ °ü·Ã µµ¸Å»ó °á°Ý»çÀ¯¸¦ ½Å¼³ÇßÀ¸¸ç, ±¹¹Î¿¬±Ý¹ý °³Á¤¾ÈÀº ´ëüÅõÀÚ ½Ã ESG ¿ä¼Ò °í·Á ±âÁØÀ» ¸¶·ÃÇß´Ù.
ÀÔ¹ýºÎ¿¡¼ Åë°úµÈ °üÇÒ º¸°Ç¡¤º¹Áö¡¤ÀÇ·á ¹ý¾ÈµéÀÇ Á¦¡¤°³Á¤ »ç½ÇÀ» ¾Ë¸®°í ÇâÈÄ ½ÃÇà ÀÏÁ¤À» ¾È³»ÇÏ´Â °ÍÀº Á¤ºÎ ºÎóÀÇ ´ç¿¬ÇÑ ÇàÁ¤ ÀýÂ÷´Ù.
´Ù¸¸ ±¹È¸ ÀÔ¹ý ¼º°ú¿¡ ¼ù°¡¶ôÀ» ¾ñÀ¸¸ç ¸¶Ä¡ ÀÚºÎÇÒ ¸¸ÇÑ °ÅâÇÑ Á¦µµÀû Çõ½ÅÀÌ ´çÀå ¿Ï¼ºµÈ °Íó·³ Æ÷ÀåÇÏ´Â °ÍÀº º¸¿©ÁÖ±â½Ä ÇàÁ¤À̶ó´Â ÁöÀûÀ» ÇÇÇÏ±â ¾î·Æ´Ù. ¹ý¾È Åë°ú »ç½ÇÀ» È«º¸ÇÏ´Â ¼±¾ðÀû ¹ßÇ¥¿¡ ¸Ó¹° °ÍÀÌ ¾Æ´Ï¶ó, °£È£»ç ÀûÁ¤ ¹èÄ¡ ±âÁØÀÇ ½ÇÈ¿¼º ÀÖ´Â ¼ö°¡ ¿¬°è³ª ¸¶¾à·ù °ü¸® ½Ã½ºÅÛ ¿î¿µ µî ÇöÀå¿¡¼ ÀÛµ¿ÇÒ ¼ö ÀÖ´Â ±¸Ã¼ÀûÀÎ ÇÏÀ§ ¹ý·É°ú ¿¹»ê¾ÈÀ¸·Î ÁøÁ¤¼ºÀ» Áõ¸íÇØ¾ß ÇÑ´Ù.
[¿µ¹®¹ø¿ª ±â»ç-AIȰ¿ë]
Eun-kyeong Jeong, Minister of Health and Welfare, oversees the implementation as the Ministry of Health and Welfare announced that 10 bills under its jurisdiction, including the Cosmetic Industry Promotion Act and amendments to the Nursing Act, passed the National Assembly. The ministry released details regarding the newly passed legislation and upcoming enforcement schedules.
According to the ministry, the Cosmetic Industry Promotion Act establishes comprehensive support frameworks for K-beauty companies, while the revised Nursing Act mandates guidelines for appropriate nurse-to-patient ratios.
Additionally, the revised Pharmaceutical Affairs Act enforces Mandatory DUR verification for narcotic prescriptions, and the National Pension Act revision incorporates ESG standards into alternative investment guidelines.
While publicizing the legislative passage of sector-specific welfare bills and providing guidance on upcoming administrative timelines presents a plausible narrative for public health governance, skepticism remains.
Critics point out that broadcasting legislative approvals to claim executive achievements borders on administrative showmanship and excessive self-praise. Rather than relying on ceremonial publicity over passed bills, the health ministry needs practical results, such as formulating detailed enforcement decrees, securing implementation budgets, and establishing measurable monitoring systems on site.
![]() |
°¡¿äÁø ±âÀÚ gyj1119@naver.com
|











